Localized Injection of Lidocaine and Glucocorticoid for Headache Treatment — LIGHT  

Refractory Migraine Clinical Trial

Official title: Intra-Arterial Injection of Lidocaine and Glucocorticoid in the Treatment of Intractable Headaches

Status Not yet recruiting

Clinical Trial Summary

The goal of this clinical trial is to test whether injecting lidocaine and steroids into two blood vessels of the brain can help treat chronic headaches (migraines).

The main questions this study aims to answer are:

• Is this treatment safe for chronic migraine patients?

• Is this treatment effective for chronic migraine patients?

Participants will:

• Be treated once with lidocaine and steroid infused into the middle meningeal arteries (two blood vessels in the brain).

• Attend appointments scheduled 1 week, 6 weeks, and 12 weeks after the treatment for a checkup.

• Keep a log of their symptoms.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Headache
• Refractory Migraine

• NCT number: NCT06462781
• Study type: Interventional
• Source: The Cooper Health System
• Contact: Lynne Kohler
• Phone: 855-306-3876
• Email: kohler-lynne@cooperhealth.edu
• Status: Not yet recruiting
• Phase: Phase 2
• Start date: March 2025
• Completion date: March 2027